drugset / Trial / NCT01799590
Continuous Treatment Study of Topiramate in Migraine Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of topiramate in participants with migraine (type of severe headache that occurs periodically and is often associated with nausea, vomiting and constipation or diarrhea) who completed the JNS019-JPN-02 study.
Timeline
- Start
- 2007-08
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 50 mg | — |
| Subject | Topiramate | Small molecule | 100 mg | — |